Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

MP Healthcare Venture Management

Profile and portfolio

Parent Mitsubishi Tanabe PharmaHQ Boston, United StatesFounded 2008

MP Healthcare Venture Management is the corporate venture arm of Mitsubishi Tanabe Pharma, a pharmaceutical and biotech company. It was founded in 2008 and is based in Boston, United States. It invests from seed to Series C+. Sectors it names: biotech and life sciences.

IPOsS2
3

Every figure links to its source

Snapshot

Investment stage: Seed to Series C+
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeed to Series C+
SectorsBiotech and life sciences
GeographyNorth America, Europe
OfficesBoston, United States

Sources: S1 MP Healthcare about us page (archived copy).

Graphic 1 of 2

Investment stage: Seed to Series C+

Sources: S1 MP Healthcare about us page (archived copy).

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
IPOs3IPOsStated by the firmS2
Companies on the firm's portfolio page25companiesCounted from the firm's own listS2

Sources: S2 MP Healthcare portfolio page (archived copy).

Graphic 2 of 2

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S2 MP Healthcare portfolio page (archived copy).

Download:Report a correction

Where it invests

Geography

Headquarters
Boston, United States

Investment regionsS1

Key facts

FactValueStatusSource
Parent companyMitsubishi Tanabe PharmaSingle sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
Founded2008Single sourceS2
HeadquartersBoston, United StatesSingle sourceS3
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
Exits9 total, 3 IPOsSingle sourceS2
StagesSeed, Series A, Series B, Series C+Single sourceS1

Investments by year

YearNewTotalSource
200833S2
200922S2
201011S2
201133S2
201211S2
201522S2
201722S2
201811S2
201911S2
202022S2
202155S2
202211S2

Notable outcomes

IPOs and acquisitions of portfolio companies. Price shown only where published.

CompanyTypeYearAcquirer or exchangeSource
CovagenAcquisition2014J&JS2
FerroKin BiosciencesAcquisition2012ShireS2
RigontecAcquisition2017MerckS2
GenkyotexIPO2014IPOS2
Genocea BiosciencesIPO2014IPOS2
miRagen TherapeuticsIPO2017IPOS2

Portfolio

The firm's portfolio page lists 25 companies.S2

Shared portfolio with other corporate VCs

7 companies on the MP Healthcare Venture Management portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
M Ventures3TRIMTECH Therapeutics, Outrun Therapeutics, ribometrix
Mitsui & Co. Global Investment1QurAlis
Sanofi Ventures1QurAlis
Pfizer Ventures1TRIMTECH Therapeutics
KDDI Open Innovation Fund1EditForce
Taiho Ventures1LiberoThera
Boehringer Ingelheim Venture Fund1Rigontec

Companies backed by the most corporate VCs

Every company on the MP Healthcare Venture Management list

25 companies, as listed on the firm's own website: 16 listed, 9 exited.S2 Read the firm's list.

Listed 16

  • Blacksmith Medicines
  • Capsigen
  • EditForce
  • F-star
  • Forge Therapeutics
  • Korro Bio
  • LiberoThera
  • Outrun Therapeutics
  • PharmEnable
  • QurAlis
  • Ribometrix
  • SOLA
  • Sonde
  • Syndexa
  • Thrasos Therapeutics
  • TRIMTECH Therapeutics

Exited 9

  • Covagen
  • FerroKin Biosciences
  • Genkyotex
  • Genocea Biosciences
  • Intradigm
  • miRagen Therapeutics
  • PharmEste
  • Pronota
  • Rigontec

Recent rounds

DateCompanyRoundAmountLed by the firmSource
2025-03-05TRIMTECH TherapeuticsSeedUSD 31MNoS4

Official pages

Read the firm's own pages for current information.

  • Website www.mp-healthcare.com/
  • Portfolio web.archive.org/web/2026/https://www.mp-healthcare.com/portfolio

Sources

  1. S1MP Healthcare about us page (archived copy)Firm
  2. S2MP Healthcare portfolio page (archived copy)Firm
  3. S3MP Healthcare home page (archived copy)Firm
  4. S4SV Health Investors: TRIMTECH Therapeutics raises $31M seed fundingPortfolio company

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by MP Healthcare Venture Management or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.